Community Center

Dr. Mazen Hanna, cardiologist at the Cleveland Clinic and co-director of the Amyloid Program, explains how cardiac amyloidosis can originate from two very different…

With increasing recognition and more accessible diagnostic tools, ATTR-CM can no longer be overlooked in patients with atypical heart failure presentations. Dr.…

What is Attruby? Attruby is a prescription medicine used to treat adults with a disease that affects the heart muscle called cardiomyopathy of wild-type or variant…

Once staging is complete, treatment planning must be individualized based on disease severity, subtype (wild-type vs. hereditary), and comorbid conditions. This…

 Join us live to explore how ATTR-CM treatment success can be measured in clinical practice.Register here: https://ow.ly/XM8w50ZjBVXThis CME-accredited webinar…

AL amyloidosis can feel overwhelming — but understanding it doesn’t have to be. Join us to learn how the disease is diagnosed, what available treatment options and…

Atrial fibrillation affects up to 70% of patients with ATTR-CM—but how does it impact treatment outcomes?Dr. Brett Sperry and I discuss new findings showing that…

The Test That Diagnoses Sickle Cell Disease 🩸 #HemoglobinElectrophoresis #SickleCellDisease

Heart Health Matters: Learn About ATTR-CM (ATTR-Cardiac Amyloidosis) ATTR-CM is a progressive condition caused by a buildup of abnormal proteins in the heart,…

Signs and Symptoms of Transthyretin Amyloid Cardiomyopathy (ATTR-CM). See link below